Yoji Hyodo

11PUBLICATIONS
10CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 03, 2026
Association between RANK gene polymorphism and early femoral neck bone loss in kidney transplant recipients.

|Jul 19, 2026
Prognostic Significance of the Modified Glasgow Prognostic Score and Systemic Immune-Inflammation Index in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Cabazitaxel.

|Mar 14, 2026
Real-World Safety and Early Effectiveness of First-Line Enfortumab Vedotin Plus Pembrolizumab with Routine Dexamethasone Premedication in Advanced Urothelial Carcinoma.

Takuto Hara, Naoto Wakita, Taisuke Tobe

|Feb 13, 2026
Kidney transplantation after chronic active Epstein-Barr virus infection remission.

Yuki Tashiro, Yoji Hyodo, Satoshi Kitamura

|Jan 18, 2026
Prognostic Impact of Initial Prostate Specific Antigen Half-Life After Abiraterone Acetate in High-Volume Metastatic Hormone-Sensitive Prostate Cancer: Who May Need Triplet Therapy?

Kotaro Suzuki, Hideto Ueki, Naoto Wakita

|Sep 03, 2025
Hepatitis B Boosters Using a Different Product vs. the Same Product for Kidney Transplant Recipients: A Retrospective Study With Bayesian Inference.

Kentaro Iwata, Shunkichi Ikegaki, Yoji Hyodo

Pageof 2

Frequent Collaborators

6 joint publications

Kotaro Suzuki

6 joint publications

Takuto Hara

6 joint publications

Tomoaki Terakawa

5 joint publications

Jun Teishima